188813-08-3

Basic information

• Product Name: (3-bromo-5-iodophenyl)methanol
• Synonyms: (3-bromo-5-iodophenyl)methanol;3-Bromo-5-iodobenzyl alcohol
• CAS NO: 188813-08-3
• Molecular Formula: C₇H₆BrIO
• Molecular Weight: 312.93041
• Mol File: 188813-08-3.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3-bromo-5-iodophenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-5-iodophenyl)methanol(188813-08-3)
• EPA Substance Registry System: (3-bromo-5-iodophenyl)methanol(188813-08-3)

Safety Data

• Hazardous Substances Data: 188813-08-3(Hazardous Substances Data)

Usage

General Description

(3-bromo-5-iodophenyl)methanol is a chemical compound with the molecular formula C6H4BrIO. It is a substituted phenylmethanol with bromine and iodine as substituents on the phenyl ring. (3-bromo-5-iodophenyl)methanol is used in organic synthesis and chemical research as a building block for various pharmaceuticals and agrochemicals. It is also used as a reagent in the synthesis of other organic compounds. (3-bromo-5-iodophenyl)methanol has potential applications in the development of new drugs and other bioactive molecules due to its unique structure and properties.

Upstream product

• 188815-32-9 3-bromo-5-iodo-benzoic acid 
• 188813-07-2 methyl 3-bromo-5-iodobenzoate 
• 7732-18-5 water 

Downstream Products

• 945867-08-3 3-bromo-5-[2-(triisopropylsilyl)ethynyl]benzyl alcohol 
• 289039-21-0 3-bromo-5-iodobenzonitrile 
• 1194488-70-4 N-(3-bromo-5-iodobenzyl)cyclopropanamine 

Relevant articles and documents

Intrastrand foldamer crosslinking by reductive amination

A series of m-phenylene ethynylene (mPE) foldamers were crosslinked in their helical conformation using a reductive amination-based strategy. This was accomplished by placing aldehyde moieties in the backbone of the oligomer at specific residues, which al

Design and Optimization of 3′-(Imidazo[1,2- a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors

DDR1 is considered as a promising target for cancer therapy, and selective inhibitors against DDR1 over other kinases may be considered as promising therapeutic agents. Herein, we have identified a series of 3′-(imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]

Magnetic resonance imaging/fluorescence dual modality protocol using designed phosphonate ligands coupled to superparamagnetic iron oxide nanoparticles

A simple and versatile methodology to tailor the surface of superparamagnetic iron oxide nanoparticles (SPIONs), and render additional fluorescence capability to these contrast agents, is reported. The dual modality imaging protocol was developed by designing multi-functional scaffolds with a combination of orthogonal moieties for aqueous dispersion and stealth, to covalently link them to SPIONs, and carry out post-functionalization of nanoparticles. SPIONs stabilized with ligands incorporating surface-anchoring phosphonate groups, ethylene glycol backbone for aqueous dispersion, and free surface exposed OH moieties were coupled to near-infrared dye Cy5.5A. Our results demonstrate that design of multi-tasking ligands with desired combination and spatial distribution of functions provides an ideal platform to construct highly efficient dual imaging probes with balanced magnetic, optical and cell viability properties.